Biotechnology
Compare Stocks
5 / 10Stock Comparison
ELAB vs AEYE vs ALKT vs HOFV vs MSFT
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Software - Application
Entertainment
Software - Infrastructure
ELAB vs AEYE vs ALKT vs HOFV vs MSFT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Biotechnology | Software - Application | Software - Application | Entertainment | Software - Infrastructure |
| Market Cap | $45K | $98M | $1.92B | $2M | $3.08T |
| Revenue (TTM) | $-1M | $40M | $472M | $17M | $318.27B |
| Net Income (TTM) | $-7M | $-3M | $-50M | $-63M | $125.22B |
| Gross Margin | 72.8% | 78.3% | 57.4% | 63.0% | 68.3% |
| Operating Margin | -75.7% | -7.9% | -9.3% | -158.0% | 46.8% |
| Forward P/E | — | — | 23.0x | — | 24.8x |
| Total Debt | $0.00 | $721K | $354M | $249M | $112.18B |
| Cash & Equiv. | $4M | $5M | $63M | $432K | $30.24B |
ELAB vs AEYE vs ALKT vs HOFV vs MSFT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 23 | May 26 | Return |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | 100 | 0.0 | -100.0% |
| AudioEye, Inc. (AEYE) | 100 | 184.1 | +84.1% |
| Alkami Technology, … (ALKT) | 100 | 78.9 | -21.1% |
| Hall of Fame Resort… (HOFV) | 100 | 9.6 | -90.4% |
| Microsoft Corporati… (MSFT) | 100 | 109.5 | +9.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ELAB vs AEYE vs ALKT vs HOFV vs MSFT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ELAB is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 44.1%, EPS growth 86.0%, 3Y rev CAGR 13.4%
- 44.1% revenue growth vs HOFV's -12.1%
AEYE lags the leaders in this set but could rank higher in a more targeted comparison.
ALKT ranks third and is worth considering specifically for value.
- Better valuation composite
Among these 5 stocks, HOFV doesn't own a clear edge in any measured category.
MSFT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 19 yrs, beta 0.85, yield 0.8%
- 7.8% 10Y total return vs AEYE's 96.5%
- Lower volatility, beta 0.85, Low D/E 32.7%, current ratio 1.35x
- Beta 0.85, yield 0.8%, current ratio 1.35x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 44.1% revenue growth vs HOFV's -12.1% | |
| Value | Better valuation composite | |
| Quality / Margins | 39.3% margin vs HOFV's -366.2% | |
| Stability / Safety | Beta 0.85 vs ELAB's 3.94 | |
| Dividends | 0.8% yield; 19-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | -4.5% vs ELAB's -99.7% | |
| Efficiency (ROA) | 19.2% ROA vs ELAB's -44.6%, ROIC 24.9% vs -82.7% |
ELAB vs AEYE vs ALKT vs HOFV vs MSFT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
ELAB vs AEYE vs ALKT vs HOFV vs MSFT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSFT leads in 4 of 6 categories
ELAB leads 0 • AEYE leads 0 • ALKT leads 0 • HOFV leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSFT leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MSFT and ELAB operate at a comparable scale, with $318.3B and -$1M in trailing revenue. MSFT is the more profitable business, keeping 39.3% of every revenue dollar as net income compared to HOFV's -3.7%. On growth, ALKT holds the edge at +28.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | -$1M | $40M | $472M | $17M | $318.3B |
| EBITDAEarnings before interest/tax | -$4M | -$504,000 | -$12M | -$10M | $192.6B |
| Net IncomeAfter-tax profit | -$7M | -$3M | -$50M | -$63M | $125.2B |
| Free Cash FlowCash after capex | -$7M | $2M | $44M | -$11M | $72.9B |
| Gross MarginGross profit ÷ Revenue | +72.8% | +78.3% | +57.4% | +63.0% | +68.3% |
| Operating MarginEBIT ÷ Revenue | -75.7% | -7.9% | -9.3% | -158.0% | +46.8% |
| Net MarginNet income ÷ Revenue | -2.5% | -7.6% | -10.6% | -3.7% | +39.3% |
| FCF MarginFCF ÷ Revenue | -2.2% | +5.5% | +9.4% | -64.5% | +22.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -45.8% | +7.9% | +28.9% | -33.3% | +18.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +100.0% | +29.0% | -22.7% | -2.0% | +23.4% |
Valuation Metrics
Evenly matched — ELAB and ALKT each lead in 2 of 5 comparable metrics.
Valuation Metrics
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $45,021 | $98M | $1.9B | $2M | $3.08T |
| Enterprise ValueMkt cap + debt − cash | -$4M | $93M | $2.2B | $251M | $3.17T |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | -31.44x | -39.07x | -0.04x | 30.43x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 22.99x | — | 24.77x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 1.62x |
| EV / EBITDAEnterprise value multiple | — | — | — | — | 19.46x |
| Price / SalesMarket cap ÷ Revenue | 0.02x | 2.42x | 4.33x | 0.11x | 10.94x |
| Price / BookPrice ÷ Book value/share | 0.01x | 20.31x | 5.16x | 0.03x | 9.02x |
| Price / FCFMarket cap ÷ FCF | — | — | 46.49x | — | 43.06x |
Profitability & Efficiency
MSFT leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
MSFT delivers a 33.1% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $-2 for HOFV. AEYE carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to HOFV's 3.45x. On the Piotroski fundamental quality scale (0–9), MSFT scores 6/9 vs HOFV's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -78.4% | -47.8% | -14.0% | -2.1% | +33.1% |
| ROA (TTM)Return on assets | -44.6% | -9.5% | -5.9% | -17.6% | +19.2% |
| ROICReturn on invested capital | -82.7% | -42.4% | -8.6% | -6.7% | +24.9% |
| ROCEReturn on capital employed | -33.7% | -17.7% | -9.3% | -7.9% | +29.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 3 | 3 | 6 |
| Debt / EquityFinancial leverage | — | 0.15x | 0.98x | 3.45x | 0.33x |
| Net DebtTotal debt minus cash | -$4M | -$5M | $290M | $249M | $81.9B |
| Cash & Equiv.Liquid assets | $4M | $5M | $63M | $432,174 | $30.2B |
| Total DebtShort + long-term debt | $0 | $721,000 | $354M | $249M | $112.2B |
| Interest CoverageEBIT ÷ Interest expense | -17.68x | -2.79x | -3.73x | -1.04x | 55.65x |
Total Returns (Dividends Reinvested)
MSFT leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MSFT five years ago would be worth $17,377 today (with dividends reinvested), compared to $0 for ELAB. Over the past 12 months, MSFT leads with a -4.5% total return vs ELAB's -99.7%. The 3-year compound annual growth rate (CAGR) favors ALKT at 13.3% vs ELAB's -98.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -98.5% | -21.0% | -20.8% | 0.0% | -12.0% |
| 1-Year ReturnPast 12 months | -99.7% | -34.1% | -39.0% | -58.4% | -4.5% |
| 3-Year ReturnCumulative with dividends | -100.0% | +17.1% | +45.5% | -95.0% | +37.6% |
| 5-Year ReturnCumulative with dividends | -100.0% | -57.7% | -53.8% | -99.5% | +73.8% |
| 10-Year ReturnCumulative with dividends | -100.0% | +96.5% | -58.2% | -99.8% | +776.0% |
| CAGR (3Y)Annualised 3-year return | -98.7% | +5.4% | +13.3% | -63.1% | +11.2% |
Risk & Volatility
Evenly matched — HOFV and MSFT each lead in 1 of 2 comparable metrics.
Risk & Volatility
HOFV is the less volatile stock with a -0.62 beta — it tends to amplify market swings less than ELAB's 3.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MSFT currently trades 74.7% from its 52-week high vs ELAB's 0.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.94x | 2.18x | 1.23x | -0.62x | 0.85x |
| 52-Week HighHighest price in past year | $1236.48 | $16.39 | $31.66 | $0.90 | $555.45 |
| 52-Week LowLowest price in past year | $1.62 | $5.31 | $14.11 | $0.24 | $356.28 |
| % of 52W HighCurrent price vs 52-week peak | +0.2% | +48.0% | +56.8% | +38.9% | +74.7% |
| RSI (14)Momentum oscillator 0–100 | 37.0 | 66.5 | 56.2 | 43.5 | 57.9 |
| Avg Volume (50D)Average daily shares traded | 10.4M | 195K | 1.7M | 0 | 32.5M |
Analyst Outlook
MSFT leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: ALKT as "Buy", MSFT as "Buy". Consensus price targets imply 34.2% upside for MSFT (target: $557) vs 22.4% for ALKT (target: $22). MSFT is the only dividend payer here at 0.78% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | — | Buy |
| Price TargetConsensus 12-month target | — | — | $22.00 | — | $556.88 |
| # AnalystsCovering analysts | — | — | 12 | — | 81 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +0.8% |
| Dividend StreakConsecutive years of raises | — | 1 | 1 | 0 | 19 |
| Dividend / ShareAnnual DPS | — | — | — | — | $3.23 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | +0.6% |
MSFT leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 2 categories are tied.
ELAB vs AEYE vs ALKT vs HOFV vs MSFT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ELAB or AEYE or ALKT or HOFV or MSFT a better buy right now?
For growth investors, PMGC Holdings Inc.
(ELAB) is the stronger pick with 44. 1% revenue growth year-over-year, versus -12. 1% for Hall of Fame Resort & Entertainment Company (HOFV). Microsoft Corporation (MSFT) offers the better valuation at 30. 4x trailing P/E (24. 8x forward), making it the more compelling value choice. Analysts rate Alkami Technology, Inc. (ALKT) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ELAB or AEYE or ALKT or HOFV or MSFT?
On forward P/E, Alkami Technology, Inc.
is actually cheaper at 23. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — ELAB or AEYE or ALKT or HOFV or MSFT?
Over the past 5 years, Microsoft Corporation (MSFT) delivered a total return of +73.
8%, compared to -100. 0% for PMGC Holdings Inc. (ELAB). Over 10 years, the gap is even starker: MSFT returned +776. 0% versus ELAB's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ELAB or AEYE or ALKT or HOFV or MSFT?
By beta (market sensitivity over 5 years), Hall of Fame Resort & Entertainment Company (HOFV) is the lower-risk stock at -0.
62β versus PMGC Holdings Inc. 's 3. 94β — meaning ELAB is approximately -736% more volatile than HOFV relative to the S&P 500. On balance sheet safety, AudioEye, Inc. (AEYE) carries a lower debt/equity ratio of 15% versus 3% for Hall of Fame Resort & Entertainment Company — giving it more financial flexibility in a downturn.
05Which is growing faster — ELAB or AEYE or ALKT or HOFV or MSFT?
By revenue growth (latest reported year), PMGC Holdings Inc.
(ELAB) is pulling ahead at 44. 1% versus -12. 1% for Hall of Fame Resort & Entertainment Company (HOFV). On earnings-per-share growth, the picture is similar: PMGC Holdings Inc. grew EPS 86. 0% year-over-year, compared to -12. 2% for Alkami Technology, Inc.. Over a 3-year CAGR, ELAB leads at 1340% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ELAB or AEYE or ALKT or HOFV or MSFT?
Microsoft Corporation (MSFT) is the more profitable company, earning 36.
1% net margin versus -263. 4% for Hall of Fame Resort & Entertainment Company — meaning it keeps 36. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSFT leads at 45. 6% versus -139. 9% for HOFV. At the gross margin level — before operating expenses — AEYE leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ELAB or AEYE or ALKT or HOFV or MSFT more undervalued right now?
On forward earnings alone, Alkami Technology, Inc.
(ALKT) trades at 23. 0x forward P/E versus 24. 8x for Microsoft Corporation — 1. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MSFT: 34. 2% to $556. 88.
08Which pays a better dividend — ELAB or AEYE or ALKT or HOFV or MSFT?
In this comparison, MSFT (0.
8% yield) pays a dividend. ELAB, AEYE, ALKT, HOFV do not pay a meaningful dividend and should not be held primarily for income.
09Is ELAB or AEYE or ALKT or HOFV or MSFT better for a retirement portfolio?
For long-horizon retirement investors, Hall of Fame Resort & Entertainment Company (HOFV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
62)). PMGC Holdings Inc. (ELAB) carries a higher beta of 3. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HOFV: -99. 8%, ELAB: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ELAB and AEYE and ALKT and HOFV and MSFT?
These companies operate in different sectors (ELAB (Healthcare) and AEYE (Technology) and ALKT (Technology) and HOFV (Communication Services) and MSFT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ELAB is a small-cap high-growth stock; AEYE is a small-cap quality compounder stock; ALKT is a small-cap high-growth stock; HOFV is a small-cap quality compounder stock; MSFT is a mega-cap quality compounder stock. MSFT pays a dividend while ELAB, AEYE, ALKT, HOFV do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.